Your search returned 8 results.

Results
	1.	Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW. MedStar authors: Ratner, Robert E PMID: 26982008 Year: 2016 Citation: Journal of Clinical Endocrinology & Metabolism. 101(5):2056-62, 2016 May Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D DOI: https://dx.doi.org/10.1210/jc.2015-4202 Add to cart (remove)
	2.	A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. MedStar authors: Ratner, Robert E PMID: 25603459 Year: 2015 Citation: Journal of Clinical Endocrinology & Metabolism. 100(5):1855-62, 2015 May. Institution: MedStar Health Research Institute Medline publication type: Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Adam KP, Banerji M, Bray GA, Buchanan TA, Clement SC, Cobb JE, DeFronzo RA, Ferrannini E, Gall W, George T, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D DOI: http://dx.doi.org/10.1210/jc.2014-3824 Add to cart (remove)
	3.	Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW. MedStar authors: Ratner, Robert E PMID: 24705615 Year: 2014 Citation: Diabetes Care. 37(6):1706-11, 2014 Jun. Institution: MedStar Health Research Institute Medline publication type: Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Form of publication: Journal Article All authors: Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D DOI: http://dx.doi.org/10.2337/dc13-1745 Add to cart (remove)
	4.	Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors: Ratner, Robert E PMID: 24650952 Year: 2014 Citation: Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T DOI: http://dx.doi.org/10.1016/j.jdiacomp.2014.01.012 Add to cart (remove)
	5.	Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro. [] MedStar authors: Ratner, Robert E PMID: 24898300 Year: 2014 Citation: Diabetes Care. 37(8):2317-25, 2014 Aug. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Ahren B, Chow FC, Fonseca VA, Gross JL, Harmony 6 Study Group, Johnson SL, Leiter LA, Miller D, Ratner RE, Rosenstock J, Stewart MW, Yang F DOI: http://dx.doi.org/10.2337/dc14-0001 Add to cart (remove)
	6.	Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors: Ratner, Robert E PMID: 23175674 Year: 2013 Citation: Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb. Institution: MedStar Health Research Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Form of publication: Journal Article All authors: Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D DOI: http://dx.doi.org/10.1161/ATVBAHA.112.300346 Add to cart (remove)
	7.	Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). MedStar authors: Ratner, Robert E PMID: 21359834 Year: 2012 Citation: The International Journal of Cardiovascular Imaging. 28(3):455-65, 2012 Mar. Institution: MedStar Health Research Institute Medline publication type: Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: APPROACH study group, Brugaletta S, Garcia-Garcia HM, Garg S, Huang C, Kolatkar NS, Kravitz BG, Miller DM, Morocutti G, Nesto RW, Ratner RE, Serruys PW DOI: http://dx.doi.org/10.1007/s10554-011-9836-z Add to cart (remove)
	8.	The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. MedStar authors: Aroda, Vanita R Ratner, Robert E PMID: 25706240 Year: 2015 Citation: Journal of Clinical Endocrinology & Metabolism. 100(4):1646-53, 2015 Apr. Institution: MedStar Health Research Institute Medline publication type: Journal Article Multicenter Study Observational Study Randomized Controlled Trial Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Ackermann RT, Aroda VR, Barrett-Connor E, Christophi CA, Delahanty LM, Diabetes Prevention Program Research Group, Edelstein SL, Herman WH, Knowler WC, Montez MG, Ratner RE, Zhang P, Zhuo X DOI: http://dx.doi.org/10.1210/jc.2014-3761 Add to cart (remove)

Powered by Koha